home / stock / biovf / biovf quote
Last: | $22.87 |
---|---|
Change Percent: | 5.06% |
Open: | $23.735 |
Close: | $22.87 |
High: | $23.735 |
Low: | $22.87 |
Volume: | 3,000 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$22.87 | $23.735 | $22.87 | $23.735 | $22.87 | 3,000 | 04-18-2024 |
$25 | $0 | $25 | $0 | $0 | 30 | 04-17-2024 |
$25 | $25 | $25 | $25 | $25 | 100 | 04-01-2024 |
$26.948 | $26.948 | $26.948 | $26.948 | $26.948 | 800 | 03-22-2024 |
$27.79 | $27.79 | $27.79 | $27.79 | $27.79 | 100 | 03-12-2024 |
$27.1671 | $27.1671 | $27.1671 | $27.1671 | $27.1671 | 110 | 03-08-2024 |
$26.2 | $26.2 | $26.2 | $26.2 | $26.2 | 500 | 03-07-2024 |
$23.75 | $0 | $23.75 | $0 | $0 | 1 | 03-05-2024 |
$23.75 | $23.75 | $23.75 | $23.75 | $23.75 | 180 | 02-29-2024 |
$25.495 | $25.495 | $25.495 | $25.495 | $25.495 | 330 | 02-23-2024 |
$23.32 | $0 | $23.32 | $0 | $0 | 127 | 02-14-2024 |
$23.32 | $23.32 | $23.32 | $23.32 | $23.32 | 296 | 02-13-2024 |
$27 | $0 | $27 | $0 | $0 | 40 | 02-08-2024 |
$27 | $27 | $27 | $27 | $27 | 100 | 01-23-2024 |
$27 | $0 | $27 | $0 | $0 | 10 | 01-22-2024 |
$27 | $0 | $27 | $0 | $0 | 90 | 01-19-2024 |
$27 | $0 | $27 | $0 | $0 | 1 | 01-11-2024 |
$27 | $27 | $27 | $27 | $27 | 500 | 01-10-2024 |
$26.725 | $26.725 | $26.725 | $26.725 | $26.725 | 500 | 01-05-2024 |
$26.25 | $26.25 | $26.25 | $26.25 | $26.25 | 200 | 01-02-2024 |
News, Short Squeeze, Breakout and More Instantly...
Swedish Orphan Biovit Ord Company Name:
BIOVF Stock Symbol:
OTCMKTS Market:
CenterPoint Energy Inc (Holding Co) (CNP) is expected to report $0.37 for Q3 2023 The Hershey Company (HSY) is expected to report $2.47 for Q3 2023 ASE Technology Holding Co. Ltd. American Depositary Shares (each representing Two) (ASX) is expected to report for Q3 2023 Reliance Steel...
Swedish Orphan Biovitrum AB (BIOVF) is expected to report $0.09 for Q3 2023
As the respiratory virus season kicks off, healthcare providers are racing against time to offer Pfizer Inc's (NYSE: PFE) vaccine, Ab...